Global Multiplex Biomarker Imaging Market Overview:
Multiplex Biomarker Imaging is used to extract more and accurate information about the diseased tissues. Multiplexed staining approaches are expected to increase the amount of information that can be obtained from intact tumor anatomy as well as to delineate the spatial and temporal expression information. Multiplexed biomarker imaging can help expose the spatial associations between stromal and immune cells within tumors, allowing for more detailed characterization. Due to multiplexed biomarkers, with just tiny sample material, researchers can get detailed information quickly.
- Need of Rapid Precision Profiling in Tumour Biology
- Need to Visualize Multiple Biomarkers
- Growing Research in The Multiplex Biomarker Imaging for More Accurate and Rapid Results
- Complex Nature of Biomarker Validation Hindering Multiplex Biomarker Imaging
- Increasing Investment in Cancer Treatment Will Boost the Demand of Multiplex Biomarker Imaging
- Rapid Commercialization of Multiplex Biomarker Imaging Technology Will Increase Its Demand
- High Cost Associated with Multiplex Biomarker Imaging
Some of the key players profiled in the report are Bio-Rad Laboratories, Inc. (United States), Ultivue Inc. (United States), Luminex Corporation (United States), Merck KGaA (Germany), BioTek Instruments, Inc (United States), Akoya Biosciences (United States), BioreclamationIVT. ELEVATING SCIENCE (United States), Applied Micro Arrays (United States), Pacific Biomarkers (United States) and PerkinElmer Inc (United States). Considering Market by Components, the sub-segment i.e. Kits will boost the Multiplex Biomarker Imaging market. Considering Market by End User, the sub-segment i.e. Research Institutes will boost the Multiplex Biomarker Imaging market.
Latest Market Insights:
On 9th April 2020, Bio-Rad Laboratories, Inc., leader of life science research and clinical diagnostic products, announced that it has acquired Celsee, Inc., a company that offers instruments and consumables for the isolation, detection, and analysis of single cells. Terms of the acquisition were not disclosed. Bio-Rad will discuss the acquisition in more detail during its first-quarter 2020 financial results conference call.
On 9th Nov 2017, Ultivue announced the commercial launch of InSituPlex Services, which provides transformative tissue interrogation of protein biomarker expression patterns. The service is based on the company's patented InSituPlex technology, which allows for impartial biomarker analysis in tissue at the high multiplex and spatial resolution.
What Can be Explored with the Multiplex Biomarker Imaging Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Multiplex Biomarker Imaging Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Multiplex Biomarker Imaging
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Multiplex Biomarker Imaging market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Multiplex Biomarker Imaging market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Multiplex Biomarker Imaging Providers, Suppliers and Distributors, Government Regulatory and Research Organizations, End-Use Industries and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.